๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
HCW Biologics Inc. (HCWB)
NASDAQ: HCWB ยท Real-Time Price ยท USD
0.7351
-0.0288 (-3.77%)
At close: Nov 19, 2026, 4:00 PM EST
0.7200
-0.0151 (-2.05%)
After-hours: Nov 19, 2026, 7:57 PM EST

HCW Biologics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
6.760.052.572.846.72-
Revenue Growth
1502.05%-97.89%-9.68%-57.73%--
Gross Profit
6.470.010.960.562.59-
Operating Income
-7.48-13.66-28.16-25.72-15.08-13.37
Net Income
-22.8-22.3-30.02-24.99-14.9-12.86
Earnings Per Share
-18.56-63.78-185.75-166.96-99.83-164.46
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.961.954.673.632.0636.71
Total Debt
6.836.8113.696.456.6-
Net Cash (Debt)
-5.88-4.86-9.02-2.8625.4636.71
Net Cash Growth
-----30.65%365.41%
Net Cash Per Share
-4.78-13.89-55.79-19.08170.58469.42

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--13.39-14.23-22.51-10.39-10.98
Capital Expenditures
---0.26-6.2-10.28-0.05
Free Cash Flow
--13.39-14.49-28.72-20.66-11.02
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
95.72%20.00%37.38%19.72%38.48%-
Operating Margin
-110.67%-25192.71%-1096.95%-904.96%-224.32%-
Pretax Margin
-57.98%-14677.14%-1169.70%-879.52%-221.67%-
Profit Margin
-337.19%-41117.24%-1169.70%-879.52%-221.67%-
FCF Margin
--24693.20%-564.48%-1010.51%-307.36%-

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.2448.357.7415.5110.22-